| Literature DB >> 18640028 |
Florian Lordick1, Theo Ruers, Daniela E Aust, Laurence Collette, Robert J Downey, Mostafa El Hajjam, Patrick Flamen, Karen Haustermans, David Ilson, Catherine Julié, Bernd Joachim Krause, Hartwig Newiger, Katja Ott, Arnaud Roth, Eric Van Cutsem, Wolfgang A Weber, Manfred P Lutz.
Abstract
Metabolic imaging and early response assessment by positron emission tomography (PET) are gaining importance in guiding treatment of localised and metastatic gastrointestinal tumours. During a workshop organised by the European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group the most relevant research questions, methodological aspects and unmet clinical needs in this disease were discussed. Potential future trials were drafted. This paper reviews the lectures and discussions held during this workshop and summarises the action points for the further investigation of metabolic imaging to guide treatment in gastrointestinal tumours.Entities:
Mesh：
Year: 2008 PMID： 18640028 DOI： 10.1016/j.ejca.2008.06.005
Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162